Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones (Q51664843)

9 April 2018

title

Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

0 references

J. H. Iser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

P. N. Maton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

G. M. Murphy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

R. H. Dowling

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

language of work or name

English

0 references

publication date

1 June 1978

1 reference

9 April 2018

10 June 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=656777

full work available at URL

18 July 2022

https://europepmc.org/articles/PMC1605021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

https://europepmc.org/articles/PMC1605021?pdf=render

18 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A656777

18 July 2022

1 reference

9 April 2018

volume

1

1 reference

9 April 2018

issue

6126

1 reference

9 April 2018

page(s)

1509-1512

1 reference

9 April 2018

The control of bile acid pool size: Effect of jejunal resection and phenobarbitone on bile acid metabolism in the rat

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Determination of hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in man

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Effects of Oral Contraceptives on the Gallbladder Bile of Normal Women

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Effects of obesity and caloric intake on biliary lipid metabolism in man

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

The value of radiology in predicting gallstone type when selecting patients for medical treatment

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Gallbladder disease in hyperlipoproteinaemia

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Bile composition in patients with high risk of cholelithiasis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1605021

Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones

14 August 2018

1 reference

12 December 2020

The cholesterol saturation index of human bile

1 reference

12 December 2020

The Lithogenic Index—-A Numerical Expression for the Relative Lithogenicity of Bile

1 reference

12 December 2020

Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral

1 reference

12 December 2020

Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism

1 reference

12 December 2020

The solubility of cholesterol in aqueous solutions of bile salts and lecithin

1 reference

12 December 2020

The simple measurement of obesity

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.6126.1509

1 reference

9 April 2018

PMCID

1605021

1 reference

9 April 2018

1 reference

9 April 2018